LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients

Trial Profile

LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2016

At a glance

  • Drugs Ledipasvir/sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms LIVE-C-Free
  • Most Recent Events

    • 28 Mar 2016 Protocol amended as phase changed from 3 to 4, treatment arms changed from 2 to 4 as reported by ClinicalTrials.gov.
    • 28 Mar 2016 Planned End Date changed from 1 Feb 2018 to 1 Jun 2018 as reported by ClinicalTrials.gov.
    • 28 Mar 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Jun 2017 as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top